WEST PHARMACEUTICAL SERVICES INC (WST)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 766,500 | 698,000 | 746,900 | 702,100 |
| Cost of goods and services sold | 492,600 | 466,100 | 482,200 | 472,100 |
| Gross profit | 273,900 | 231,900 | 264,700 | 230,000 |
| Research and development | 19,100 | 16,300 | 15,500 | 17,500 |
| Selling, general and administrative expenses | 95,900 | 88,000 | 83,500 | 83,000 |
| Other expense (income) (note 14) | -5,200 | -20,600 | -4,400 | -3,300 |
| Operating profit | 153,700 | 107,000 | 161,300 | 126,200 |
| Interest income | 3,600 | 4,100 | 4,600 | 4,000 |
| Interest expense, net | 100 | 400 | - | 1,500 |
| Other nonoperating expense (income) | -200 | -200 | -700 | - |
| Interest expense, net | - | - | 700 | - |
| Income before income taxes and equity in net income of affiliated companies | 157,000 | 110,500 | 164,500 | 128,700 |
| Equity in net income of affiliated companies | 5,000 | 3,400 | 3,900 | 4,500 |
| Income tax expense | 30,200 | 24,100 | 32,400 | 21,900 |
| Net income | 131,800 | 89,800 | 136,000 | 111,300 |
| Basic (in dollars per share) | 1.82 | 1.24 | 1.87 | 1.52 |
| Basic (in shares) | 72,200,000 | 72,500,000 | 72,800,000 | 73,000,000 |
| Diluted (in dollars per share) | 1.82 | 1.23 | 1.85 | 1.51 |
| Diluted (in shares) | 72,500,000 | 73,000,000 | 73,400,000 | 73,700,000 |